EUVIMEDEUVIMED entdecken
Crossref

Structurally Engineered Carbonized Polycatechin for Targeting VEGF Signaling and Oxidative Stress in Corneal Neovascularization

Wan-Jo Lee, Hung-Wen Tsai, Yu-Jia Lee, Hong-Jyuan Jian, Choa-Wei Chen, Jui-Yang Lai iD, Chih-Ching Huang iD, Mei-Lan Ko, Hsuan-Chieh Lin, Yu-Fen Huang iD

Advanced Healthcare Materials · 2026-06 · 15 (21)

DOI: 10.1002/adhm.202505049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.04.2026. Verfasst von Wan-Jo Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan. Hauptthemen laut MEDLINE: Oxidative Stress, Catechin, Vascular Endothelial Growth Factor A, Corneal Neovascularization. Die Arbeit nennt 86 Literaturangaben. Gefördert von: National Science and Technology Council, National Tsing Hua University, National Taiwan University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal neovascularization (CNV) is a condition where abnormal blood vessels grow into the cornea, potentially leading to opacification and blindness. This process is driven by the overexpression of vascular endothelial growth factor (VEGF) and its interaction with the VEGF receptor‐2 (VEGFR‐2), stimulating angiogenesis. The oxidative stress induced by reactive oxygen species accumulation further promotes the growth of new blood vessels, exacerbating the condition. Therefore, developing a multifaceted treatment capable of inhibiting the VEGF‐VEGFR‐2 interaction and mitigating oxidative stress is critical. Catechin (Ch), known for its antioxidant, anti‐inflammatory, and anti‐angiogenic properties, faces limitations in medical use due to its poor bioactivities, low solubility in water, and instability. This research introduced carbonized‐polycatechin (c‐pCh) to treat CNV, prepared by mild pyrolysis of Ch at 210°C and subsequently undergoing polymerization in an alkaline environment. c‐pCh exhibits superior anti‐angiogenic capabilities by blocking VEGF‐VEGFR‐2 interaction and reducing oxidative stress‐induced angiogenesis. In a rat model of CNV induced by sutures, c‐pCh outperformed monomeric Ch in treatment efficacy. The combined process of carbonization and polymerization presents a promising strategy for developing herbal nanomedicines with enhanced biocompatibility and bioactivity. The outcomes of this study underscore the potent therapeutic potential of c‐pCh in CNV management, leveraging its multiple actions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressCatechinVascular Endothelial Growth Factor ACorneal NeovascularizationSignal TransductionAnimalsRatsVascular Endothelial Growth Factor Receptor-2Rats, Sprague-DawleyHumansMaleAngiogenesis Inhibitors

Stichwörter der Autor:innen

angiogenesis inhibitorscarbonized nanomaterialsmultifaceted treatmentocular diseasesphytochemicals

Substanzen

CatechinVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Angiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan.
  • Department of Biomedical Engineering and Center for Biomedical Engineering, Chang Gung University, Taoyuan, Taiwan.
  • Institute of Analytical and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan.
  • Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
  • Department of Materials Engineering, Ming Chi University of Technology, New Taipei City, Taiwan.
  • Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan, Taiwan.

ORCID-Profile: Jui-Yang Lai, Chih-Ching Huang, Yu-Fen Huang

Förderung

  • National Science and Technology Council
  • National Tsing Hua University
  • National Taiwan University Hospital

Zitieren

APA

Lee, W. J., Tsai, H. W., Lee, Y. J., Jian, H. J., Chen, C. W., Lai, J. Y., Huang, C. C., Ko, M. L., Lin, H. C., & Huang, Y. F. (2026). Structurally Engineered Carbonized Polycatechin for Targeting VEGF Signaling and Oxidative Stress in Corneal Neovascularization. Advanced Healthcare Materials, 15(21). https://doi.org/10.1002/adhm.202505049

Vancouver

Lee WJ, Tsai HW, Lee YJ, Jian HJ, Chen CW, Lai JY, et al. Structurally Engineered Carbonized Polycatechin for Targeting VEGF Signaling and Oxidative Stress in Corneal Neovascularization. Advanced Healthcare Materials. 2026;15(21). doi:10.1002/adhm.202505049

BibTeX
@article{Lee2026,
  author = {Lee, Wan-Jo and Tsai, Hung-Wen and Lee, Yu-Jia and Jian, Hong-Jyuan and Chen, Choa-Wei and Lai, Jui-Yang and Huang, Chih-Ching and Ko, Mei-Lan and Lin, Hsuan-Chieh and Huang, Yu-Fen},
  title = {Structurally Engineered Carbonized Polycatechin for Targeting VEGF Signaling and Oxidative Stress in Corneal Neovascularization},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {21},
  doi = {10.1002/adhm.202505049}
}
Kostenlos starten →